15 participants
Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-07-21
- Start Date:
- 2008-06-18
- Completion:
- 2011-02-18
Conditions
- Neoplasms, Ovarian
Interventions
- DRUG
No Results Yet